LITERATURE REVIEW MOLECULAR-GENETIC RESERCH IN NON-ALCOHOLIC FATTY LIVER DISEASE.
;
liver cirrhosis, non-alcoholic fatty liver disease, superoxide dismutase, polymorphism.Abstrak
The article relates to the study of literature on the subject of genetic polymorphism genes of xenobiotic detoxification in liver cirrhosis, one of the important issues in the area of internal diseases.
Iqtiboslar
Babak, O.Ya. Chronic hepatitis. - Kyiv: Publishing house. "Blitz-Inform", 1999. -208 p.
Baranov, V.S. [and others] Human genome and “predisposition” genes / V.S. Baranov, E.V. Baranova, T.E. Ivashchenko [and others] //
Introduction to predictive medicine. - St. Petersburg: Intermedica, 2000. - 272 p.
Diseases of the liver and biliary tract: a guide for doctors / ed. V.T. Ivashkina. – M: LLC “Publishing house “MVesti”,
- 416 p.
Vinogradova, S.V. The role of polymorphism of cytokine genes in the development of liver diseases // Suchasna gastroenterology. - 2004. -
No. 5. - pp. 15-18.
Hepatitis. Rational diagnostics and therapy / ed. M. Fuchs. - M.: GEOTAR-Media, 2010. - 240 p.
Goncharova, I.A. [and others] Genomic basis of susceptibility to infectious diseases / I.A. Goncharova, M.B. Freidin,
A.A. Rudko [and others] // Bulletin of the Vavilov Society of Genetics and Breeders. - 2006. - T.10, No. 3. - P. 540-552.
Goncharova, I.A. [and others] Pathogenetics of liver cirrhosis: polymorphism of glutathione-S-transferase genes / I.A. Goncharova, M.I.
Rachkovsky, E.V. Beloborodova [and others] //Molecular biology. - 2010. - T.44, No. 3.- P. 431-438.
Grigoriev, P.Ya. [and others] Clinical gastroenterology / P.Ya. Grigoriev, Yakovenko A.V. - M.: Medical information
agency, 2004.- 704 p.
Ivashkin, V.T. [and others] Risk factors for the development of hepatocellular carcinoma / V.T. Ivashkin, M.A. Morozova, M.I. Mayevskaya
[and others] // Russian Journal of Gastroenterology, Hepatology, Coloproctology. - 20091.
Bellentani S., Scaglioni F., Marino M., Bedogni G. Epidemiology of non-alcoholic fatty liver disease. Dig. Dis. 2010;28:155–61. Doi: 10.1159/000282080.
Rolo A.P., Teodoro J.S., Palmeira C.M. Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis. Free Radic. Biol. Med. 2012;52:59–69. Doi: 10.1016/j.freeradbiomed.2011.10.003.
Belfort R., Harrison S.A., Brown K., et al. A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis N. Engl. J. Med. 2006;355:2297–307. DOI: 10.1056/NEJMoa060326.
Betrapally N.S., Gillevet P.M., Bajaj J.S. Changes in the Intestinal Microbiome and Alcoholic and Nonalcoholic Liver Diseases: Causes or Effects? Gastroenterology. 2016;150(8):1745–55. Doi: 10.1053/j.gastro.2016.02.073.
Caldwell S.H., Swerdlow R.H., Khan E.M., et al. Mitochondrial abnormalities in non-alcoholic steatohepatitis. Hepatol. 1999;31:430–34.
Chatham J., Chacko V.P., Arnold C., et al. Alterations in H. liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study. JAMA. 1999;282:1659–64.
Serviddio G., Bellanti F., Tamborra R., et al. Alterations of hepatic ATP homeostasis and respiratory chain during development of non-alcoholic steatohepatitis in a rodent model. Eur. J. Clin. Invest. 2008;38:245–52. Doi 10.1111/j.1365-2362.2008.01936.x.
Betrapally N.S., Gillevet P.M., Bajaj J.S. Changes in the Intestinal Microbiome and Alcoholic and Nonalcoholic Liver Diseases: Causes or Effects? Gastroenterology. 2016;150(8):1745–55. Doi: 10.1053/j.gastro.2016.02.073.
